Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioxcel Therapeutics Inc.

1.96
+0.09004.81%
Post-market: 1.90-0.0592-3.02%18:21 EDT
Volume:58.08K
Turnover:111.66K
Market Cap:10.72M
PE:-0.08
High:1.98
Open:1.90
Low:1.87
Close:1.87
Loading ...
Nov 12, 2020

Major Issues Report

8-K - Current report
Aug 14, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2020

Major Issues Report

8-K - Current report
Jul 31, 2020

Major Issues Report

8-K - Current report
Jul 27, 2020

Major Issues Report

8-K - Current report
Jun 24, 2020

Major Issues Report

8-K - Current report
May 21, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 21, 2020

Major Issues Report

8-K - Current report
May 14, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2020

Major Issues Report

8-K - Current report
Apr 15, 2020

Major Issues Report

Current report, items 7.01, 8.01, and 9.01
Mar 09, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 09, 2020

Major Issues Report

Current report, items 2.02 and 9.01
Mar 06, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 24, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 21, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 19, 2020

Major Issues Report

Current report, items 2.02 and 8.01
Feb 18, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Feb 07, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals